Frames presidential health transparency as eroding, with Trump’s case exemplifying growing opacity
The article highlights patterns of delayed or corrected disclosures (e.g., CT scan misstated as MRI), refusal to explain drug use changes, and reliance on anonymous officials—all suggesting institutional lack of openness. It positions this as part of a broader trend of declining transparency.
“Nearly three months after the visit, and after initially telling reporters that he had undergone an MRI exam, Trump and the White House clarified that the president had received a CT scan as part of his assessment.”